Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Asset Utilization Ratio for 16 consecutive years, with 0.45 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 13.51% to 0.45 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45 through Dec 2025, up 13.51% year-over-year, with the annual reading at 0.43 for FY2025, 3.93% up from the prior year.
  • Asset Utilization Ratio hit 0.45 in Q4 2025 for Integra Lifesciences Holdings, roughly flat from 0.45 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.37 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.41 across 5 years, with a median of 0.41 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: fell 16.4% in 2021 and later increased 16.84% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.41 in 2021, then fell by 0.85% to 0.4 in 2022, then grew by 1.27% to 0.41 in 2023, then dropped by 3.03% to 0.4 in 2024, then increased by 13.51% to 0.45 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IART at 0.45 in Q4 2025, 0.45 in Q3 2025, and 0.42 in Q2 2025.